Support Our Future Leaders

The Media Line is known for producing truthful, unbiased journalism and we are teaching future journalists to do the same. Through our signature Press and Policy Student Program, The Media Line provides an innovative opportunity for students to globalize their educational experience by connecting to an active news bureau in the Middle East, studying journalism and public policy under the mentorship of veteran journalists while earning academic credit.

These students will reshape how the world sees and understands the Middle East and, in turn, how the Middle East impacts our world. Your contribution will provide the next generation with the skills they need to uphold the highest standards of journalism and, in turn, educate our global society with integrity and respect.

Thank you!

“The Press and Policy Student Program has elevated my global awareness, supported my journalistic efforts, and propelled me on the path of future success within the news industry.”
Press and Policy Student Program Participant
Carla Warren, University of Houston
Thank you and best wishes.
 
Felice Friedson
Founder, President

Coronavirus Updates

Iran imposes 10-day shutdown to halt virus spread
The Media Line Staff
10:49 | 04/11/2021

Iran ordered a 10-day lockdown in 23 of the country’s 31 provinces beginning on Saturday as a fourth wave of the coronavirus has engulfed the country. Iran has logged more than 2 million cases of the coronavirus, with more than 64,000 deaths. The upsurge in cases is in part a result of travel and celebrations during the recent Nowruz Persian New Year celebrations. Gatherings will be forbidden during the upcoming Muslim holy month of Ramadan.

South African variant can overcome Pfizer vaccine
The Media Line Staff
10:36 | 04/11/2021

Israeli researchers have discovered that the South African variant of the coronavirus can overcome the protection offered by the Pfizer vaccine. The study by Tel Aviv University and Israel’s largest health care provider, Clalit, was released on Saturday. The study, which had a small sample size due to its lack of prevalence in Israel, only looked at people who had already tested positive for COVID-19, not at overall infection rates.

Study: 1 in 3 COVID-19 survivors develop brain condition
The Media Line Staff
13:34 | 04/07/2021

One in three people who recover from the coronavirus received a neurological or psychiatric diagnosis within six months, a new study has found. The report in The Lancet Psychiatry journal showed that patients ill with the coronavirus were more likely to develop a brain condition than patients with the flu or other respiratory tract infections.

All US adults eligible for vaccine by April 19
Marcy Oster
11:21 | 04/07/2021

President Joe Biden announced that every adult in the United States over the age of 18 will be eligible to receive a vaccination against the coronavirus beginning on April 19. the announcement moves the up date by which all states must make vaccines available for all adults by two week, from May 1. Biden said during his announcement on Tuesday that new variants of the coronavirus are spreading quickly throughout the country, and that both cases and hospitalizations are going up.

AstraZeneca vaccine trial in children put on hold
The Media Line Staff
11:13 | 04/07/2021

The University of Oxford announced that it has suspended the trial of a COVID-19 vaccine in children and teenagers. The announcement issued on Tuesday said it was waiting for data on rare blood clotting issues from Britain’s Medicines and Healthcare Products Regulatory Agency before it decides whether to resume the trial. There have been 30 such blood clotting cases in Britain. Seven of those cases were fatal.

Iran receives first COVAX vaccine doses
The Media Line Staff
12:51 | 04/06/2021

More than 700,000 doses of the AstraZeneca vaccine against the coronavirus arrived in Iran on Monday night. The delivery is the first of the more than 16 million doses Iran purchased through COVAX, the global initiative aimed at providing equitable access to COVID-19 vaccines for poorer countries. Iran has three homegrown vaccines currently in human trials.

Report: Pfizer halts vaccine shipments to Israel
The Media Line Staff
19:07 | 04/05/2021

Pfizer held up a shipment of 700,000 doses of its vaccine against the coronavirus over concern that a transitional government will not pay the bill. The shipment had been expected to arrive on Sunday, The Jerusalem Post reported. Pfizer told the newspaper that it had fulfilled its initial agreement with Israel for vaccines, and that it is working with the government to renegotiate the agreement and provide more doses. Additional doses would make it possible to inoculate pre-teens and children, and have doses on hand for booster shots should they become necessary.

Cases in India top 100,000 in a day
The Media Line Staff
19:00 | 04/05/2021

India registered more than 100,000 new cases of the coronavirus a in a day, becoming the second country in the world after the United States to do so. On Monday, India registered 103,558 new cases, for a total of 12.6 million since the start of the pandemic. The country eased restrictions on mask wearing and social distancing in February.

CDC warns against travel to Israel over Palestinian cases
The Media Line Staff
18:53 | 04/05/2021

The US Centers for Disease Control warned against travel to Israel due to the “very high level” of cases of the coronavirus, after lumping it together with the West Bank and Gaza. The CDC warned against the “Very High Level of COVID-19 in Israel, including the West Bank and Gaza,” in its travel advisory released on Monday. Israel has seen very low number of new infections, but cases in Gaza and the West Bank are on the rise.

Netherlands suspends administering AstraZeneca shots
The Media Line Staff
12:48 | 04/04/2021

The Netherlands stopped giving the AtraZeneca vaccine against the coronavirus after reports on Friday that at least five people developed blood clots following their vaccinations. At least one person reportedly died. Some 400,000 vaccines were given during that time period. The Health Ministry in the Netherlands is investigating whether the blood clots were caused by the vaccination. Germany also has suspended using the AstraZeneca vaccine for people under age 60 due to a small number of reported blood clots.

1 2 3 138 139 140
Wake up to the Trusted Mideast News source Mideast Daily News Email
By subscribing, you agree to The Media Line terms of use and privacy policy.